Economic and disease burden of dengue in Southeast Asia.

<h4>Background</h4>Dengue poses a substantial economic and disease burden in Southeast Asia (SEA). Quantifying this burden is critical to set policy priorities and disease-control strategies.<h4>Methods and findings</h4>We estimated the economic and disease burden of dengue i...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Donald S Shepard, Eduardo A Undurraga, Yara A Halasa
Formato:	article
Lenguaje:	EN
Publicado:	Public Library of Science (PLoS) 2013
Materias:	Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270
Acceso en línea:	https://doaj.org/article/887ab6e31e5d4886a55cd6a9a3809d78
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:887ab6e31e5d4886a55cd6a9a3809d78
record_format	dspace
spelling	oai:doaj.org-article:887ab6e31e5d4886a55cd6a9a3809d782021-11-18T09:15:21ZEconomic and disease burden of dengue in Southeast Asia.1935-27271935-273510.1371/journal.pntd.0002055https://doaj.org/article/887ab6e31e5d4886a55cd6a9a3809d782013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23437406/?tool=EBIhttps://doaj.org/toc/1935-2727https://doaj.org/toc/1935-2735<h4>Background</h4>Dengue poses a substantial economic and disease burden in Southeast Asia (SEA). Quantifying this burden is critical to set policy priorities and disease-control strategies.<h4>Methods and findings</h4>We estimated the economic and disease burden of dengue in 12 countries in SEA: Bhutan, Brunei, Cambodia, East-Timor, Indonesia, Laos, Malaysia, Myanmar, Philippines, Singapore, Thailand, and Viet Nam. We obtained reported cases from multiple sources--surveillance data, World Health Organization (WHO), and published studies--and adjusted for underreporting using expansion factors from previous literature. We obtained unit costs per episode through a systematic literature review, and completed missing data using linear regressions. We excluded costs such as prevention and vector control, and long-term sequelae of dengue. Over the decade of 2001-2010, we obtained an annual average of 2.9 million (m) dengue episodes and 5,906 deaths. The annual economic burden (with 95% certainty levels) was US$950m (US$610m-US$1,384m) or about US$1.65 (US$1.06-US$2.41) per capita. The annual number of disability-adjusted life years (DALYs), based on the original 1994 definition, was 214,000 (120,000-299,000), which is equivalent to 372 (210-520) DALYs per million inhabitants.<h4>Conclusion</h4>Dengue poses a substantial economic and disease burden in SEA with a DALY burden per million inhabitants in the region. This burden is higher than that of 17 other conditions, including Japanese encephalitis, upper respiratory infections, and hepatitis B.Donald S ShepardEduardo A UndurragaYara A HalasaPublic Library of Science (PLoS)articleArctic medicine. Tropical medicineRC955-962Public aspects of medicineRA1-1270ENPLoS Neglected Tropical Diseases, Vol 7, Iss 2, p e2055 (2013)
institution	DOAJ
collection	DOAJ
language	EN
topic	Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270
spellingShingle	Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 Donald S Shepard Eduardo A Undurraga Yara A Halasa Economic and disease burden of dengue in Southeast Asia.
description	<h4>Background</h4>Dengue poses a substantial economic and disease burden in Southeast Asia (SEA). Quantifying this burden is critical to set policy priorities and disease-control strategies.<h4>Methods and findings</h4>We estimated the economic and disease burden of dengue in 12 countries in SEA: Bhutan, Brunei, Cambodia, East-Timor, Indonesia, Laos, Malaysia, Myanmar, Philippines, Singapore, Thailand, and Viet Nam. We obtained reported cases from multiple sources--surveillance data, World Health Organization (WHO), and published studies--and adjusted for underreporting using expansion factors from previous literature. We obtained unit costs per episode through a systematic literature review, and completed missing data using linear regressions. We excluded costs such as prevention and vector control, and long-term sequelae of dengue. Over the decade of 2001-2010, we obtained an annual average of 2.9 million (m) dengue episodes and 5,906 deaths. The annual economic burden (with 95% certainty levels) was US$950m (US$610m-US$1,384m) or about US$1.65 (US$1.06-US$2.41) per capita. The annual number of disability-adjusted life years (DALYs), based on the original 1994 definition, was 214,000 (120,000-299,000), which is equivalent to 372 (210-520) DALYs per million inhabitants.<h4>Conclusion</h4>Dengue poses a substantial economic and disease burden in SEA with a DALY burden per million inhabitants in the region. This burden is higher than that of 17 other conditions, including Japanese encephalitis, upper respiratory infections, and hepatitis B.
format	article
author	Donald S Shepard Eduardo A Undurraga Yara A Halasa
author_facet	Donald S Shepard Eduardo A Undurraga Yara A Halasa
author_sort	Donald S Shepard
title	Economic and disease burden of dengue in Southeast Asia.
title_short	Economic and disease burden of dengue in Southeast Asia.
title_full	Economic and disease burden of dengue in Southeast Asia.
title_fullStr	Economic and disease burden of dengue in Southeast Asia.
title_full_unstemmed	Economic and disease burden of dengue in Southeast Asia.
title_sort	economic and disease burden of dengue in southeast asia.
publisher	Public Library of Science (PLoS)
publishDate	2013
url	https://doaj.org/article/887ab6e31e5d4886a55cd6a9a3809d78
work_keys_str_mv	AT donaldsshepard economicanddiseaseburdenofdengueinsoutheastasia AT eduardoaundurraga economicanddiseaseburdenofdengueinsoutheastasia AT yaraahalasa economicanddiseaseburdenofdengueinsoutheastasia
_version_	1718420913293099008

Economic and disease burden of dengue in Southeast Asia.

Ejemplares similares